New drug may limit disease progression, provide better symptom relief to Parkinson's
|
Research paper:
D-512, a novel dopamine D2 / D3 receptor agonist, demonstrates superior anti-parkinsonian efficacy over ropinirole in parkinsonian rats, Lindenbach et al., Br J Pharmacol July 1 2017. D-512, a novel dopamine D2 / D3 receptor agonist, demonstrates superior anti-parkinsonian efficacy over ropinirole in parkinsonian rats - Lindenbach - 2 17 - British Journal of Pharmacology - Wiley Online Library |
All times are GMT -5. The time now is 03:08 PM. |
Powered by vBulletin Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.